Hamm Robert A 4
4 · BIOGEN IDEC INC. · Filed Apr 26, 2010
Insider Transaction Report
Form 4
BIOGEN IDEC INC.BIIB
Hamm Robert A
EVP, Pharma. Oper. & Tech.
Transactions
- Sale
Common Stock
2010-04-23$52.20/sh−2,138$111,603→ 28,625.41 total - Sale
Common Stock
2010-04-23$52.19/sh−703$36,690→ 27,212.41 total - Sale
Common Stock
2010-04-23$52.20/sh−2,117$110,504→ 30,763.41 total - Sale
Common Stock
2010-04-23$52.16/sh−710$37,032→ 27,915.41 total
Footnotes (6)
- [F1]Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
- [F2]Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, the issuer, or a security holder of the issuer.
- [F3]This represents the weighted average price for shares sold at a range between $52.00 (low) and $52.39 (high).
- [F4]This represents the weighted average price for shares sold at a range between $52.00 (low) and $52.44 (high).
- [F5]This represents the weighted average price for shares sold at a range between $52.01 (low) and $52.42 (high).
- [F6]This represents the weighted average price for shares sold at a range between $52.03 (low) and $52.4425 (high).